MAP3K2 and prostate adenocarcinoma: Such as BCL2L11 and MAP3K2 were considerably regulated by miRNA markers in UCEC and PRAD of our study (Figure 6), which were consistent with the previous studies (Fulford et al., 2016; Fialkova et al., 2017).